Clinical nutrition and drug interactions
- PMID: 25931873
- PMCID: PMC4382818
- DOI: 10.5152/UCD.2013.112013
Clinical nutrition and drug interactions
Abstract
A drug's plasma level, pharmacological effects or side effects, elimination, physicochemical properties or stability could be changed by interactions of drug-drug or drug-nutrition products in patients who receive enteral or parenteral nutritional support. As a result, patients might experience ineffective outcomes or unexpected effects of therapy (such as drug toxicity, embolism). Stability or incompatibility problems between parenteral nutrition admixtures and drugs might lead to alterations in expected therapeutic responses from drug and/or parenteral nutrition, occlusion in venous catheter or symptoms or mortality due to infusion of composed particles. Compatibilities between parenteral nutrition and drugs are not always guaranteed in clinical practice. Although the list of compatibility or incompatibilities of drugs are published for the use of clinicians in their practices, factors such as composition of parenteral nutrition admixture, drug concentration, contact time in catheter, temperature of the environment and exposure to light could change the status of compatibilities between drugs and nutrition admixtures. There could be substantial clinical changes occurring in the patient's nutritional status and pharmacological effects of drugs due to interactions between enteral nutrition and drugs. Drug toxicity and ineffective nutritional support might occur as a result of those predictable interactions. Although administration of drugs via feeding tube is a complex and problematic route for drug usage, it is possible to minimise the risk of tube occlusion, decreased effects of drug and drug toxicity by using an appropriate technique. Therefore, it is important to consider pharmacological dosage forms of drugs while administering drugs via a feeding tube. In conclusion, since the pharmacists are well-experienced and more knowledgeable professionals in drugs and drug usage compared to other healthcare providers, it is suggested that provision of information and drug counselling by pharmacists in terms of detection and prevention of problems (such as interactions, stability, incompatibility) related with enteral/parenteral nutrition and drugs are invaluable in clinical practice.
Keywords: Parenteral nutrition; drug interactions; enteral nutrition; incompatibility.
Similar articles
-
Parenteral nutrition compatibility and stability: Practical considerations.Nutr Clin Pract. 2024 Oct;39(5):1150-1163. doi: 10.1002/ncp.11189. Epub 2024 Jul 12. Nutr Clin Pract. 2024. PMID: 38994914 Review.
-
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.JPEN J Parenter Enteral Nutr. 1999 Mar-Apr;23(2):67-74. doi: 10.1177/014860719902300267. JPEN J Parenter Enteral Nutr. 1999. PMID: 10081995
-
[Polypharmacy and enteral nutrition in patients with complex chronic diseases].Nutr Hosp. 2017 May 8;34(Suppl 1):57-76. doi: 10.20960/nh.1240. Nutr Hosp. 2017. PMID: 28585857 Review. Spanish.
-
Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.Eur J Pharm Sci. 2017 Jan 1;96:449-455. doi: 10.1016/j.ejps.2016.10.015. Epub 2016 Oct 12. Eur J Pharm Sci. 2017. PMID: 27742594
-
Medication administration through enteral feeding tubes.Am J Health Syst Pharm. 2008 Dec 15;65(24):2347-57. doi: 10.2146/ajhp080155. Am J Health Syst Pharm. 2008. PMID: 19052281 Review.
Cited by
-
Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital.Eur J Clin Nutr. 2017 Feb;71(2):164-168. doi: 10.1038/ejcn.2016.147. Epub 2016 Aug 10. Eur J Clin Nutr. 2017. PMID: 27507069
-
Administration of Potential Medications for COVID-19 Treatment Through Feeding Tube.Turk J Pharm Sci. 2021 Jun 18;18(3):250-251. doi: 10.4274/tjps.galenos.2021.52223. Turk J Pharm Sci. 2021. PMID: 34157813 Free PMC article. No abstract available.
-
In vitro optimization of crushed drug-sensitive antituberculosis medication when administered via a nasogastric tube.Microbiol Spectr. 2024 Jan 11;12(1):e0287623. doi: 10.1128/spectrum.02876-23. Epub 2023 Nov 22. Microbiol Spectr. 2024. PMID: 37991379 Free PMC article.
-
Consumer's Opinion on a Pharmacist's Role in Nutritional Counseling.Innov Pharm. 2021 Apr 7;12(2):10.24926/iip.v12i2.3634. doi: 10.24926/iip.v12i2.3634. eCollection 2021. Innov Pharm. 2021. PMID: 34345515 Free PMC article.
References
-
- Chan LN. Drug-nutrient interaction in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2002;5:327–332. - PubMed
-
- Teitelbaum D, Guenter P, Howell WH, Kochevar ME, Roth J, Seidner DL. Definition of terms, style, and conventions used in A.S.P.E.N. guidelines and standards. Nutr Clin Pract. 2005;20:281–285. - PubMed
-
- Hadaway LC. Administering parenteral nutrition with other I.V. drugs. Nursing. 2005;35:26. - PubMed
-
- Sacks GS. Drug-nutrient considerations in patients receiving parenteral and enteral nutrition. Practical Gastroenterology. 2004;19:39–48.
-
- Mattox TW, Reiter PD. Parenteral nutrition. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York: Appleton & Lange; 2005. pp. 2591–2613.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials